4Forrest A, Parsons M. The enhanced spontaneous activity of the diabetic colon is not the consequence of impaired inhibitory control mechanisms. Auton Autacoid Pharmacol 2003; 23:149-158
5El-Salhy M. The possible role of the gut neuroendocrine system in diabetes gastroenteropathy. Histol Histopathol 2002; 17:1153-1161
6Said SI, Mutt V. Polypeptide with broad biological activity. isolation from small intestine. Science 1970;169:1217-1218
7Rekik M, Delvaux M, Frexinos J, Bueno L. Role of vasoactive intestinal polypeptide in the adaptation of intestinal smooth muscle cells to mechanical distension J. Pharmacol Exp Ther 1998; 287:832-838
8El-Salhy M. Gastrointestinal transit in an animal model of human diabetes type 2- relationship to gut neuroendocrine peptide contents. Ups J Med Sci 2002; 107:101-110
9Lysy J, Karmeli F, Sestieri M, Yatzkan Y, Goldin E.Decreased substance P content in the rectal mucosa of diabetics with diarrhea and constipation. Metabolism 1997; 46:730-734
10Corleto VD, Romano G, Severi C, Annibale B, Nasoni S, Strom R, Jensen RT, Delle Fave G. Human circular colonic smooth muscle cells possess active somatostatin receptors. Ital J Gastroenterol Hepatol 1998; 30:505-509
